COPD Flare-ups PSP Engagement Summary

Gathering uncertainties

Methods used (eg, survey, focus groups, interviews): Survey

	Number	%
Total respondents (across all methods)	571	100
Total patients and carers	457	80
Total health and care professionals	110	19
Total number of original uncertainties submitted	1912	100
Original uncertainties in scope	791	41.4
Original uncertainties out of scope	1121	58.6

Interim prioritisation

Methods used (eg, survey, focus groups, interviews): Survey

	Number	%
Total number of indicative questions (answered & unanswered)	59	100
Number of verified answered questions	7	12
Number of verified unanswered questions	52	88
Number of verified unanswered questions included in the interim prioritisation	51
Total respondents (across all methods)	191	100
Total patients and carers	83	44
Total health and care professionals	101	53
Number of questions taken to final workshop	16

Final priority setting workshop

	Number	%
Total participants	14	100
Total patients and carers	7	50
Total health and care professionals	7	50

Notes

This section includes risks and benefits of miscellaneous other interventions in the treatment of COPD exacerbations.” This indicative unanswered question has been removed from the interim analysis because the steering group felt that this question will not add any new information and it is mostly covered by other questions.

Total number of participants includes “others”, (4 in the first survey and 7 in the interim survey).